Thank you for claiming your business. Kindly check your Email for verification mail from Sulekha.com Our team will contact you shortly!.
About Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, developing and providing novel, small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases. Rigel's pioneering research focuses on signaling pathways that are critical to disease mechanisms.
Our business strategy is to transition to a commercial-stage company with our Phase 3 results from fostamatinib in immune thrombocytopenic purpura (ITP). We continue to build an extensive portfolio of products, monetizing select assets through attractive partnerships.